Cost of care of haemophilia with inhibitors
Author:
Publisher
Wiley
Subject
Genetics(clinical),Hematology,General Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2516.2009.02100.x/fullpdf
Reference49 articles.
1. 1 DiMichele D . Inhibitors to factor VIII - epidemiology and treatment. In: LeeCA, HootsK, BerntorpE eds. Textbook of Hemophilia. Oxford: Blackwell Science, 2005: 64-70.
2. The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977-99;UK Haemophilia Centre Doctors’ Organization;J Thromb Haemost,2004
3. Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers);Mannucci;Haemophilia,2007
4. Italian guidelines for the diagnosis and treatment of patients with haemophilia and inhibitors;Gringeri;Haemophilia,2005
5. Utilization of care in haemophilia: a resource-based method for cost-analysis from the Haemophilia Utilization Group Study;Globe;Haemophilia,2004
Cited by 61 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. HOMOEOPATHIC MANAGEMENT OF TARGETED HAEMARTHROSES IN INHIBITOR POSITIVE HAEMOPHILIAC: A CASE REPORT;International Journal of Research -GRANTHAALAYAH;2024-01-13
2. Simoctocog alfa (Nuwiq®) in children: early steps in life’s journey for people with severe hemophilia A;Therapeutic Advances in Hematology;2024-01
3. Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan;Haemophilia;2023-10-11
4. Simoctocog alfa (Nuwiq®) in previously untreated patients with severe haemophilia A—Final efficacy and safety results from the NuProtect study;European Journal of Haematology;2023-07-13
5. Plasma‐derived FVIII/VWF complex shows higher protection against inhibitors than isolated FVIII after infusion in haemophilic patients: A translational study;Haemophilia;2022-06-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3